Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T23:10:02.322Z Has data issue: false hasContentIssue false
  • English
  • Français

An Uncontrolled Open Trial of a Brief Behavioural Activation Treatment for Depression in Patients with Chronic Spontaneous Urticaria

Published online by Cambridge University Press:  26 February 2019

Matthew T. Tull Open the ORCID record for Matthew T. Tull [Opens in a new window] ,
Claire B. Rosenblatt ,
Christopher R. Berghoff ,
Laura J. Dixon ,
Evan Ciarloni ,
Denise D. Montgomery ,
Linnie E. Wheeless  and
Gailen D. Marshall
Matthew T. Tull*
Affiliation:
University of Toledo, Toledo, OH, USA
Claire B. Rosenblatt
Affiliation:
University of Mississippi Medical Center, Jackson, MS, USA
Christopher R. Berghoff
Affiliation:
University of South Dakota, Vermillion, SD, USA
Laura J. Dixon
Affiliation:
University of Mississippi, Oxford, MS, USA
Evan Ciarloni
Affiliation:
University of Mississippi Medical Center, Jackson, MS, USA
Denise D. Montgomery
Affiliation:
University of Mississippi Medical Center, Jackson, MS, USA
Linnie E. Wheeless
Affiliation:
Jackson State University, Jackson, MS, USA
Gailen D. Marshall
Affiliation:
University of Mississippi Medical Center, Jackson, MS, USA
*
*Corresponding author: Matthew T. Tull, PhD, Department of Psychology, Mail Stop 948, University of Toledo, 2801 West Bancroft Street, Toledo, Ohio 43606, USA. Email: [email protected]
Get access

Abstract

Chronic spontaneous urticaria (CSU) has been associated with depression and can have an impact on quality of life. Therefore, researchers have suggested the potential utility of psychological interventions for targeting depression among CSU patients. Psychological interventions that may hold the most promise are those that are brief and easily transportable, such as brief behavioural activation treatment for depression. We report results of a preliminary investigation of an uncontrolled open trial of a one-session behavioural activation treatment for depression designed for patients with CSU (BATD-CSU) at a university-based allergy and immunology clinic. Participants were 11 females with chronic, poorly controlled urticaria and symptoms of depression. Following the completion of pretreatment questionnaires, participants were administered BATD-CSU primarily by non-mental health professionals trained and supervised in its delivery. One month post-BATD-CSU, participants completed follow-up questionnaires. Participants exhibited significant reductions in depression severity, avoidance/rumination, and work/school impairment. BATD-CSU was also associated with improvements in urticaria control one month post-treatment. Moreover, five of nine patients reported reliable and clinically significant improvement on at least one outcome. Results demonstrate that BATD-CSU may have benefits for CSU patients even when consisting of one session and delivered by professionals with limited background in psychological interventions, thus speaking to its feasibility and transportability.

Keywords

allergybehavioural therapydermatologyinterventiontreatment outcome
Type
Standard Paper
Information
Behaviour Change , Volume 36 , Issue 2 , June 2019 , pp. 75 - 83
Copyright
Copyright © The Author(s) 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barlow, DH (2002). Anxiety and its disorders (2nd ed.). New York, NY: Guilford Press.Google Scholar
Crawford, JR, Garthwaite, PH, Lawrie, CJ, Henry, JD, MacDonald, MA, Sutherland, J … Sinha, P (2009). A convenient method of obtaining percentile norms and accompanying interval estimates for self-report mood scales (DASS, DASS-21, HADS, PANAS, and sAD). British Journal of Clinical Psychology, 48, 163–180.Google Scholar
Cuijpers, P, van Straten, A and Warmerdam, L (2007). Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review, 27, 318–326.Google Scholar
Dobson, KS, Hollon, SD, Dimidjian, S, Schmaling, KB, Kohlenberg, RJ, Gallop, RJ … Jacobson, NS (2008). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology, 76, 468–477.Google Scholar
Dunlap, WP, Cortina, JM, Vaslow, JB and Burke, MJ (1996). Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods, 1, 170–177.Google Scholar
Engin, B, Uguz, F, Yilmaz, E, Özdemir, M and Mevlitoglu, I (2008). The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology, 22, 36–40.Google Scholar
Evans, C, Margison, F and Barkham, M (1998). The contribution of reliable and clinically significant change methods to evidence-based mental health. Evidence-Based Mental Health, 1, 70–72.Google Scholar
Ferrer, M (2015). Immunological events in chronic spontaneous urticaria. BMC Clinical and Translational Allergy, 5, 30.Google Scholar
Ferster, CB (1973). A functional analysis of depression. American Psychologist, 28, 857–890.Google Scholar
Gawrysiak, M, Nicholas, C and Hopko, DR (2009). Behavioral activation for moderately depressed university students: Randomized controlled trial. Journal of Counseling Psychology, 56, 468–475.Google Scholar
Grattan, CE, Sabroe, RA and Greaves, MW (2002). Chronic urticaria. Journal of the American Academy of Dermatology, 46, 645–660.Google Scholar
Gupta, MA and Gupta, AK (2003). Psychiatric and psychological co-morbidity in patients with dermatologic disorders. American Journal of Clinical Dermatology, 4, 833–842.Google Scholar
Hergüner, S, Kılıç, G, Karakoc, S, Tamay, Z, Tüzün, Ü and Güler, N (2011). Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. British Journal of Dermatology, 164, 1342–1347.Google Scholar
Hopko, DR, Lejuez, CW, Ruggiero, KJ and Eifert, GH (2003). Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clinical Psychology Review, 23, 699–717.Google Scholar
Jacobson, NS and Truax, P (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.Google Scholar
Kanter, JW, Mulick, PS, Busch, AM, Berlin, KS and Martell, CR (2006). The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment, 29, 191–202.Google Scholar
Kroenke, K, Spitzer, RL and Williams, JB (2001). The PHQ-9. Journal of General Internal Medicine, 16, 606–613.Google Scholar
Lejuez, CW, Hopko, DR, Acierno, R, Daughters, SB and Pagoto, SL (2011). Ten year revision of the brief behavioral activation treatment for depression: Revised treatment manual. Behavior Modification, 35, 111–161.Google Scholar
Lejuez, CW, Hopko, DR and Hopko, SD (2001). A brief behavioral activation treatment for depression treatment manual. Behavior Modification, 25, 255–286.Google Scholar
Lovibond, SH and Lovibond, PF (1995). Manual for the Depression Anxiety Stress Scales (2nd ed.). Sydney, Australia: Psychology Foundation of Australia.Google Scholar
Martell, CR, Addis, ME and Jacobson, NS (2001). Depression in context: Strategies for guided action. New York, NY: WW Norton and Co.Google Scholar
Özkan, M, Oflaz, SB, Kocaman, N, Özşeker, F, Gelincik, A, Büyüköztürk, S … Çolakoğlu, B (2007). Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology, 99, 29–33.Google Scholar
Roemer, L (2001). Measures for anxiety and related constructs. In Antony, MM, Orsillo, SM and Roemer, L (Eds.), Practitioner's guide to empirically based measures of anxiety (pp. 49–83). New York, NY: Guilford Press.Google Scholar
Shenefelt, PD (2010). Psychological interventions in the management of common skin conditions. Psychology Research and Behavior Management, 3, 51–63.Google Scholar
Staubach, P, Eckhardt-Henn, A, Dechene, M, Vonend, A, Metz, M, Magerl, M … Maurer, M (2006). Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. British Journal of Dermatology, 154, 294–298.Google Scholar
Takahagi, S, Mihara, S, Iwamoto, K, Morioke, S, Okabe, T, Kameyoshi, Y and Hide, M (2010). Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy, 65, 649–656.Google Scholar
Tull, MT, Berghoff, CR, Bardeen, JR, Schoenleber, M and Konkle-Parker, DJ (2018). An initial open trial of a brief behavioral activation treatment for depression and medication adherence in HIV-infected patients. Behavior Modification, 42, 196–209.Google Scholar
Weller, K, Groffik, A, Church, MK, Hawro, T, Krause, K, Metz, M … Maurer, M (2014). Development and validation of the urticarial control test: A patient-reported outcome instrument for assessing urticarial control. The Journal of Allergy and Clinical Immunology, 133, 1365–1372.Google Scholar
Weller, K, Viehmann, K, Bräutigam, M, Krause, K, Siebenhaar, F, Zuberbier, T and Maurer, M (2012). Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 10, 341–347.Google Scholar